Dr. Sicklick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92093Phone+1 858-822-6173Fax+1 858-228-5153
Summary
- Dr. Jason Sicklick is an NIH and FDA R01 funded investigator, Professor of Surgery, Executive Vice Chair of Research in the Department of Surgery, and Co-Leader of the Sarcoma Disease Team at the UC San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of complex retroperitoneal and abdominal sarcomas, including gastrointestinal stromal tumors (GIST), as well as hepatobiliary oncology. In 2016, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group, the largest GIST patient advocacy group in the world. In 2018, Dr. Sicklick was selected as a James IV Association of Surgeons fellow. This highly prestigious international traveling fellowship is designed to promote communication and collaboration in the international surgical community. In 2018 he also received the RARE Champion of Hope in Medical Care & Treatment Award from the Global Genes-Allies in Rare Disease, the largest global non-profit advocacy organization for individuals and families fighting rare and genetic diseases. In 2019, he received the Excellence in Mentoring Award from the UC San Diego Health Systems International. In 2021, he received the Rare Impact Award from the National Organization for Rare Disorders (NORD®), which aims to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers.
He received his medical degree from the UCLA School of Medicine, completed his general surgery residency at The Johns Hopkins Hospital where he was the Administrative Chief Resident, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center where he was the Chief Administrative Fellow. He joined the UC San Diego Division of Surgical Oncology at Moores Cancer Center in 2010.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2008 - 2010
- Johns Hopkins UniversityResidency, Surgery, 2000 - 2008
- David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
- CA State Medical License 2010 - 2026
- NY State Medical License 2008 - 2011
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013-2019
- Fellow American College of Surgeons
Clinical Trials
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis Start of enrollment: 2014 Jul 01
- Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers Start of enrollment: 2015 Feb 01
- Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) Start of enrollment: 2018 Sep 12
Roles: Contact, Principal Investigator, Sub-Investigator
Publications & Presentations
PubMed
- Gastrointestinal Stromal Tumor (GIST) Quiz: Test your knowledge.Sadie Munter, Ashwyn Sharma, Mark Antkowiak, Tannaz Ranjbarian, Mojgan Hosseini
Journal of Gastrointestinal Surgery. 2024-10-24 - 4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists.Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee
Cancer Communications. 2024-10-01 - Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy.Bryan H Louie, Shumei Kato, Jordan S Lim, Ki Hwan Kim, Hyo Jeong Lim
Iscience. 2024-08-16
Journal Articles
- Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune TherapeuticsJ K Sicklick, P R Cohen, Annals of Oncology
- Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal MesotheliomaSudeep Banerjee, Adam M Burgoyne, Joel Baumgartner, Amanda Kirane, Grace Y Lin, Jason Sicklick, Journal of gastrointestinal surgery
- Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma DatabaseJohn Phay, Lawrence A Shirley, Lauren M Postlewait, Carmen C Solorzano, Colleen M Kiernan, Ioannis Hatzaras, Natalie Seiser, Tracy S Wang, Ryan C Fields, Konstantinos ..., Annals of Surgical Oncology
- Join now to see all
Press Mentions
- Study Suggests Relationship Between Stromal Tumors and MesotheliomaAugust 2nd, 2022
- Ripretinib Continues to Demonstrate Benefit in Advanced GISTNovember 11th, 2021
- At Initial Cancer Diagnosis, a Deeply Personalised AssessmentOctober 14th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: